MX2016005576A - Composicion herbaria, procedimiento para su preparacion y uso de la misma. - Google Patents
Composicion herbaria, procedimiento para su preparacion y uso de la misma.Info
- Publication number
- MX2016005576A MX2016005576A MX2016005576A MX2016005576A MX2016005576A MX 2016005576 A MX2016005576 A MX 2016005576A MX 2016005576 A MX2016005576 A MX 2016005576A MX 2016005576 A MX2016005576 A MX 2016005576A MX 2016005576 A MX2016005576 A MX 2016005576A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- relates
- present
- herbal composition
- momordica charantia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
Abstract
La presente invención se refiere a un extracto estandarizado de Momordica charantia que contiene uno o más compuestos heterocíclicos que contienen nitrógeno en calidad de marcadores bioactivos y a un procedimiento para la preparación del mismo. La presente invención se refiere también a una composición que contiene el extracto estandarizado de Momordica charantia que contiene uno o más compuestos heterocíclicos que contienen nitrógeno en calidad de los marcadores bioactivos. La presente invención se refiere también al uso del extracto estandarizado de Momordica charantia o a la composición que contiene dicho extracto estandarizado para el tratamiento de trastornos metabólicos tales como diabetes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361896321P | 2013-10-28 | 2013-10-28 | |
PCT/IB2014/065649 WO2015063674A1 (en) | 2013-10-28 | 2014-10-28 | Herbal composition, process for its preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016005576A true MX2016005576A (es) | 2016-12-09 |
Family
ID=53003431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016005576A MX2016005576A (es) | 2013-10-28 | 2014-10-28 | Composicion herbaria, procedimiento para su preparacion y uso de la misma. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20160296577A1 (es) |
EP (1) | EP3062803A4 (es) |
JP (1) | JP2016535746A (es) |
KR (1) | KR20160066558A (es) |
CN (1) | CN105682670A (es) |
AU (1) | AU2014343262A1 (es) |
CA (1) | CA2928542A1 (es) |
CL (1) | CL2016000998A1 (es) |
IL (1) | IL245296A0 (es) |
MX (1) | MX2016005576A (es) |
PH (1) | PH12016500775A1 (es) |
RU (1) | RU2016120665A (es) |
WO (1) | WO2015063674A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105054253A (zh) * | 2015-07-27 | 2015-11-18 | 广西鹿寨方田贸易有限公司 | 罗汉果烘干方法 |
US10675319B2 (en) | 2016-06-21 | 2020-06-09 | Tci Co., Ltd. | Method for regulating circadian clock, regulating diurnal preference, adjusting a biological clock, improving sleep quality and/or facilitating sleep by using momordica charantia extract |
IT201700002235A1 (it) * | 2017-06-07 | 2018-12-07 | Arche Frama Srls | Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere |
SG11202000197PA (en) | 2017-07-11 | 2020-02-27 | Pfizer | Immunogenic compositions comprising cea muc1 and tert |
CN110376294B (zh) * | 2019-05-28 | 2021-07-23 | 神威药业集团有限公司 | 一种瓜蒌配方颗粒指纹图谱的构建方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6183747B1 (en) * | 1999-07-14 | 2001-02-06 | Kaijun Ren | Use of plant Momordica charactia extracts for treatment of acne acid |
RU2586770C2 (ru) * | 2011-01-28 | 2016-06-10 | Пирамал Энтерпрайзис Лимитед | Способ приготовления травяного экстракта |
CN103284083B (zh) * | 2012-02-24 | 2016-06-08 | 中科云健康科技(天津)有限公司 | 高维生素c含量的苦瓜干品及其制备方法 |
-
2014
- 2014-10-28 EP EP14857459.3A patent/EP3062803A4/en not_active Withdrawn
- 2014-10-28 RU RU2016120665A patent/RU2016120665A/ru not_active Application Discontinuation
- 2014-10-28 CN CN201480059345.2A patent/CN105682670A/zh active Pending
- 2014-10-28 CA CA2928542A patent/CA2928542A1/en not_active Abandoned
- 2014-10-28 MX MX2016005576A patent/MX2016005576A/es unknown
- 2014-10-28 AU AU2014343262A patent/AU2014343262A1/en not_active Abandoned
- 2014-10-28 KR KR1020167014056A patent/KR20160066558A/ko not_active Application Discontinuation
- 2014-10-28 WO PCT/IB2014/065649 patent/WO2015063674A1/en active Application Filing
- 2014-10-28 JP JP2016526896A patent/JP2016535746A/ja not_active Withdrawn
- 2014-10-28 US US15/031,889 patent/US20160296577A1/en not_active Abandoned
-
2016
- 2016-04-24 IL IL245296A patent/IL245296A0/en unknown
- 2016-04-26 PH PH12016500775A patent/PH12016500775A1/en unknown
- 2016-04-27 CL CL2016000998A patent/CL2016000998A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN105682670A (zh) | 2016-06-15 |
WO2015063674A1 (en) | 2015-05-07 |
CA2928542A1 (en) | 2015-05-07 |
RU2016120665A (ru) | 2017-12-01 |
US20160296577A1 (en) | 2016-10-13 |
AU2014343262A1 (en) | 2016-06-02 |
EP3062803A4 (en) | 2017-05-03 |
PH12016500775A1 (en) | 2016-05-30 |
JP2016535746A (ja) | 2016-11-17 |
KR20160066558A (ko) | 2016-06-10 |
CL2016000998A1 (es) | 2017-01-20 |
EP3062803A1 (en) | 2016-09-07 |
IL245296A0 (en) | 2016-06-30 |
RU2016120665A3 (es) | 2018-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018007022A (es) | Metodos para tratar la enfermedad de huntington. | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
WO2014062733A3 (en) | Substituted benzene compounds | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
MX2015008628A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
PH12016500775A1 (en) | Herbal composition, process for its preparation and use thereof | |
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
EP3067059A4 (en) | Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient | |
PH12016502050A1 (en) | Homovanillinic acid ester, in particular, for creating a hot and/or pungent taste sensation | |
WO2015056094A3 (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent | |
WO2015059463A3 (en) | Treatment of beta-catenin related diseases8 | |
PH12017500348A1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
MY189930A (en) | Glyt1 inhibitors for use in the treatment of hematological disorders | |
EA201590564A1 (ru) | Стабильные составы | |
MX2014013048A (es) | Derivados de pantotenato para el tratamiento de trastornos neurologicos. | |
SG11201709800RA (en) | Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient | |
EP3144005A4 (en) | Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof | |
EP3006434A4 (en) | Novel compound derived from plant of genus quamoclit and composition containing same as active ingredient for preventing or treating diabetes | |
MX2016007955A (es) | Pirrol carboxamidas iii fluorometil-sustituidas. | |
MX2016004094A (es) | Composicion farmaceutica que comprende capecitabina y ciclofosfamida. | |
PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
MX2016007956A (es) | Pirrol carboxamidas fluorometil-sustituidas como bloqueadores del canal de calcio de cav2.2. | |
PL3019182T3 (pl) | Kompozycja zawierająca oczyszczony wyciąg wyodrębniony z pseudolysimachion rotundum var. subintegrum zawierający dużą ilość składnika czynnego lub związki z niego wyodrębnione jako składnik czynny do zapobiegania lub leczenia przewlekłej obturacyjnej choroby płuc oraz jej zastosowania | |
PL3415142T3 (pl) | Kompozycja do leczenia zapalenia brzegów powiek zawierająca terpinen-4-ol | |
EA033077B1 (ru) | Фармацевтическая композиция, содержащая 13 глицеридов, и ее препараты и их применение |